Steven Hansberry

Steven Hansberry has three years of work experience in the research field. In 2019, they worked as a Research Associate at Mitokinin Inc. In 2018, they worked as a Staff Research Associate I at UCSF Medical Center. In 2017, they worked as a CIRM Bridges Fellow at the California Institute for Regenerative Medicine. At this position, they aimed to understand the mechanisms behind a severe form of Fibrodysplasia Ossificans Progressiva by using CRISPR to introduce the disease-causing point mutation into wild-type cell lines. Steven also drove forward a secondary project to establish a protocol for 3D culture of murine bone marrow. In 1901, they worked as a Research Associate at San Francisco State University, where they were part of a team which investigated organelle size homeostasis.

Steven Hansberry obtained a Bachelor of Science in Cell/Cellular and Molecular Biology from San Francisco State University in 2016, having started their studies there in 2012. Steven then continued their studies at San Francisco State University and obtained a Master of Science in Biomedical Sciences with a Concentration in Stem Cell Science in 2018.